Linking pages
- Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine news | CNN Business https://edition.cnn.com/2020/11/11/investing/pfizer-ceo-albert-bourla-stock-sale-vaccine/index.html 103 comments
- Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad | WIRED https://www.wired.com/story/covid-19-vaccines-with-minor-side-effects-could-still-be-pretty-bad/ 3 comments
Linked pages
- Breaking News, Latest News and Videos | CNN https://www.cnn.com 107852 comments
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext 2572 comments
- Moderna execs dumped nearly $30 million of stock after coronavirus vaccine news | CNN Business https://www.cnn.com/2020/05/22/investing/moderna-coronavirus-vaccine-stock-sales/index.html 89 comments
- Moderna coronavirus vaccine: Early results from trial show participants developed antibodies against the virus | CNN https://www.cnn.com/2020/05/18/health/coronavirus-vaccine-moderna-early-results/index.html 58 comments
- https://investors.modernatx.com/static-files/03ba600f-801d-4609-a7fb-332ac507f76f 38 comments
- https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine 8 comments
- In quest for vaccine, US makes 'big bet' on company with unproven technology | CNN https://www.cnn.com/2020/05/01/us/coronavirus-moderna-vaccine-invs/index.html 0 comments
- Moderna Vaccine Trial: How Upbeat Coronavirus News Fueled a Stock Surge - The New York Times https://www.nytimes.com/2020/05/23/health/coronavirus-vaccine-moderna.html 0 comments